Business Wire Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD) (the Company), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that because the Company does not believe it will be able to consummate an initial business combination within the...\n more…
Ticker Report Wolverine Asset Management LLC lessened its position in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD Get Rating) by 19.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The fund owned 64,257 ...\n more…
Ticker Report Calamos Advisors LLC bought a new position in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD Get Rating) in the fourth quarter, HoldingsChannel reports. The firm bought 1,250,000 shares of the companys stock, valued at approximately $12,850,000. Other hedge funds and ...\n more…
Zolmax Cubist Systematic Strategies LLC lifted its position in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD Get Rating) by 3.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 454,159 shares of the companys stock after purchasing an ...\n more…